The Team

BioCurate’s team has both global and local industry experience, scientific credentials, project management skills and commercial acumen, as well as a passion and commitment to create impact through translating discoveries into drugs.

150
Has over 150 years of combined biotech/pharma industry experience

35
Has been directly involved in over 35 Investigational New Drug applications (INDs)

70
Are responsible for 70 therapeutics currently in the clinic

$2.1B
Were directly involved in 15 deals worth a cumulative total of over $2.1 billion

Dr Glenn Begley
Chief Executive Officer
Dr C. Glenn Begley is a clinical haematologist and medical oncologist, whose academic and commercial roles include board level and senior positions in Australia, the USA and the UK.

Read full profile
Dr Damien Bates
Chief Scientific Officer & Head of Translational Medicine
Dr Damien Bates is a senior healthcare industry executive specialising in global preclinical and clinical development, medical affairs, marketing authorisation and lifecycle management of biologics and devices.

Read full profile
Linda Peterson
Chief Operating Officer & Company Secretary
Linda Peterson is the COO and Company Secretary for BioCurate Pty Ltd, responsible for leading and managing all aspects of the set-up and independent operations and governance of the company.

Read full profile
Dr Catherine Drinkwater
Director of Project Management
Dr Cathy Drinkwater has extensive experience in both academic research and industry drug development.

Read full profile
Dr Eric Hayes
Director of Partnerships
Dr Eric Hayes has academic, commercial drug development and pharmaceutical R&D support services experience, spanning over 25 years, in Europe, North America, Asia and Australia.

Read full profile
Dr Lorna Mitchell
Director of Small Molecule Therapeutics
Dr Lorna Mitchell is a medicinal chemist with 17 years international drug discovery experience in the biotech and pharmaceutical industry.

Read full profile
Dr Christopher Chan
Director of Protein Therapeutics
Dr Christopher Chan is an immunologist with expertise in therapeutic antibody development, immuno-oncology, inflammation, innate myeloid and lymphocyte biology, and T cell biology.

Read full profile
Dr Tifelle Reisinger
Program Manager
Dr Tifelle Reisinger is a medicinal chemist with 9 years drug discovery experience in the pharmaceutical and CRO industries in France, UK and Australia.

Read full profile
Michele Neisemann
Office Operations Manager
Michele Neisemann has extensive experience in executive administration, human resources, operations, and project management in the R&D sector.

Read full profile
Francis Kirby
Project Coordinator
Francis Kirby has project management experience in the academic and corporate sector together with a research background in the fields of Neuroscience and Immunology.

Read full profile
Paul Field
Business Development Advisor
Paul brings over 25 years of business development experience to BioCurate, and a deep network in the global biopharmaceutical industry.

Read full profile

Board of Directors

BioCurate is operationally independent and has an independent Board Chair, the Hon John Brumby, AO. Our Board of Directors has expertise in innovation, biotechnology, commercialisation, investment and corporate governance.

Discover more

 

Our Shareholders

Melbourne is home to two outstanding universities, Monash University and the University of Melbourne. Joining these two powerhouses to support the collaborative joint venture BioCurate, is the Victorian State Government, the nation’s largest investor in the life sciences.

Discover more

 

Portfolio

BioCurate’s portfolio of projects spans a number of therapeutic areas, from oncology to anti-infectives. These projects are currently receiving support from the BioCurate team and our network of local and global industry and sector partners.

Discover more